Characterization of HUH6, HEP3B, HEPG2 and HLE liver cancer cell lines by WNT/Q- catenin pathway, microrna expression and protein expression profile

Cellular and Molecular Biology

Volumn 56, Issue SUPPL.1, 2010, Pages

  Di Masi, A ^a   Viganotti, M ^b   Antoccia, A ^a   Magrelli, A ^b   Salvatore, M ^b   Azzalin, G ^c   Tosto, F ^b   Lorenzetti, S ^b   Maranghi, F ^b   Mantovani, A ^b   Macino, G ^c   Tanzarella, C ^a   Taruscio, D ^b  

^a ROMA TRE UNIVERSITY   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CTNNB1; Hepatoblastoma; Hepatocellular carcinoma; Molecular markers; WNT pathway

Indexed keywords

ABELSON KINASE; ALPHA CATENIN; APOPTOSIS INDUCING FACTOR; BETA CATENIN; CASPASE 5; CHECKPOINT KINASE 1; CLATHRIN LIGHT CHAIN; CONNEXIN 32; CYCLIN A; CYCLIN D3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 7; DNA TOPOISOMERASE; DYSTROPHIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FRIZZLED PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LYMPHOID ENHANCER FACTOR 1; MICRORNA; PHOSPHOTYROSINE; PROTEIN BCL XL; PROTEIN P53; SODIUM PROTON EXCHANGE PROTEIN 3; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 2; TRANSCRIPTION FACTOR SOX17; UNINDEXED DRUG; UVOMORULIN; WNT PROTEIN; WNT10A PROTEIN; GRB2 PROTEIN, HUMAN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MIRN150 MICRORNA, HUMAN; PROTEOME;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL STRAIN HEPG2; CYTOSKELETON; HUMAN; HUMAN CELL; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; NEUROBIOLOGY; PROTEIN EXPRESSION; PROTEIN MICROARRAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; GENE EXPRESSION PROFILING; LIVER TUMOR; METABOLISM; TUMOR CELL LINE;

BETA CATENIN; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GRB2 ADAPTOR PROTEIN; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MICRORNAS; PROTEOME; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 79952200841     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/149     Document Type: Article

References (100)

1. Abbott, A. L., Alvarez-Saavedra, E., Miska, E. A., Lau, N. C., Bartel, D. P., Horvitz, H. R., and Ambros, V., The let-7 MicroRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans. Dev. Cell 2005, 9: 403-414.
2. Aressy, B., and Ducommun, B., Cell cycle control by the CDC25 phosphatases. Anticancer Agents Med. Chem. 2008, 8: 818-824.
3. Bläker, H., Hofmann, W. J., Rieker, R. J., Penzel, R., Graf, M., and Otto, H. F. β-Catenin Accumulation and Mutation of the CTNNB1. Genes, Chromosomes & Cancer 1999, 25: 399-402.
4. Boutros, M., Paricio, N., Strutt, D. I., and David, I., Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signalling. Cell 1998, 94: 109-118.
5. Brantjes, H., Roose, J., van De Wetering, M., and Clevers, H., All Tcf HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Res. 2001, 29: 1410-1419.
6. Breuhahn, K., Longerich, T., and Schirmacher, P., Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene 2006, 25: 3787-3800.
7. Calin, G. A., Liu, C.G., Sevignani, C., Ferracin, M., Felli, N., Dumitru, C.D., Shimizu, M., Cimmino, A., Zupo, S., Dono, M., Dell'Aquila, M. L., Alder, H., Rassenti, L., Kipps, T. J., Bullrich, F., Negrini, M., and Croce, C. M., MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. USA 2004, 101: 11755-11760.
8. Calin, G. A., Cimmino, A., Fabbri, M., Ferracin, M., Wojcik, S. E., Shimizu, M., Taccioli, C., Zanesi, N., Garzon, R., Aqeilan, R.I., Alder, H., Volinia, S., Rassenti, L., Liu, X., Liu, C. G., Kipps, T. J., Negrini, M., and Croce, C. M., MiR-15a and miR-16-1 cluster functions in human leucemia. Proc. Natl. Acad. Sci. USA 2008, 105: 5166-5171.
9. Cavallo, R. A., Cox, R. T., Moline, M. M., Roose, J., Polevoy, G.A., Clevers, H., Peifer, M., and Bejsovec, A., Drosophila Tcf and Groucho interact to repress Wingless signaling activity. Nature 1998, 395: 604-608.
10. Chamorro, M. N., Schwartz, D. R., Vonica, A., Brivanlou, A. H., Cho, K. R., and Varmus, H. E., FGF20 and DKK1 are transcriptional target of ß-catenin and FGF20 is implicated in cancer and development. EMBO J. 2005, 24: 73-84.
11. Chan, J. A., Krichevsky, A. M., and Kosik, K.S., MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65: 6029-6033.
12. Chang, T.C., Yu, D., Lee, Y. S., Wentzel, E. A., Arking, D. E., West, K. M., Dang, C. V., Thomas-Tikhonenko, A., and Mendell, J. T., Widespread microRNA repression by Myc contributes to tumorigenesis. Nat. Genet. 2008, 20: 43-50.
13. Chen, C. Z., Li, L., Lodish, H. F., and Bartel,, D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303: 83-86.
14. Clevers, H., Wnt/β-Catenin Signaling in Development and Disease. Cell 2006, 127: 469-480.
15. Crawford, H. C, Fingleton, B., Gustavson, M. D., Kurpios, N., Wagenaar, R. A., Hassell, J. A., and Matrisian, L.M. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors. Oncogene 1999, 18: 2883-2891.
16. Dalmay, T., MicroRNAs and cancer. J. Intern. Med. 2008, 263: 366-375.
17. Daly, R. J., Binder, M. D., and Sutherland, R. L., Overexpression of the Grb2 gene in human breast cancer cell lines. Oncogene 1994, 9: 2723-2727.
18. Daniels, D. L., and Weis, W.I., β-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation. Nat. Struct. Mol. Biol. 2005, 12: 364-371.
19. Dayyani, F., Wang, J., Yeh, J. R. J., Ahn, E. Y., Tobey, E., Zhang, D. E., Bernstein, I. D., Peterson, R. T., and Sweetser, DA., Loss of TLE1 and TLE4 from the del9q commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival. Blood 2008, 111: 4338-4347.
20. de La Coste, A., Romagnolo, B., Billuart, P., Renard, C, Buendia, M., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C, Kahn, A., and Perret, C, Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 1998, 95: 8847-8851.
21. Dejmek, J., Safholm, A., Kamp Nielsen, C, Andersson, T., and Leandersson, K., WNT-5a/Ca2+-induced NFAT activity is counteracted by WNT-5a/Yes-Cdc42-casein kinase I signaling in human mammary epithelial cells. Mol. Cell. Biol. 2006, 26: 6024-6036.
22. Du, Y., Spence, S. E., Jenkins, N. A., and Copeland, N.G., Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis. Blood 2005, 106: 2498-2505.
23. Esau, C, Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., Subramaniam, A., Propp, S., Lollo, B. A., Freier, S., Bennett, C. F., Bhanot, S., and Monia, B.P. MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell. Met. 2006, 3: 87-98.
24. Esquela-Kerscher, A., and Slack, F. J., Oncomirs -microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6: 259-269.
25. Gramantieri, L., Ferracin, M., Fornari, F., Veronese, A., Sabbioni, S., Liu, C. G., Calin, G. A., Giovannini, C, Ferrazzi, E., Grazi, G. L., Croce, C. M., Bolondi, L., and Negrini, M., Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 2007, 67: 6092-6099.
26. He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C, Lowe1, S. W., Hannon, G. J., and Hammond, S. M. A., microRNA polycistron as a potential human oncogene. Nature 2005, 435: 828-833.
27. He, T. C, Sparks, A. B., Rago, C, Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., and Kinzler, K. W., Identification of c-MYC as a target of the APC pathway. Science 1998, 281: 1509-1512.
28. Huelsken, J. and Behrens, J., The Wnt signalling pathway. J. Cell Sci. 2002, 115: 3977-3978.
29. Ikenoue, T., Ijichi, H, Kato, N., Kanai, F., Masaki, T., Rengifo, W., Okamoto, M., Matsumura, M., Kawabe, T., Shiratori, Y., and Omata, M., Analysis of the β-Catenin/T Cell Factor Signaling Pathway in 36 Gastrointestinal and Liver Cancer Cells. Jpn. J. Cancer Res. 2002, 93: 1213-1220.
30. Iorio, M. V., Ferracin, M., Liu, C. G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., Ménard, S., Palazzo, J. P., Rosenberg, A., Musiani, P., Volinia, S., Nenci, I., Calin, G. A., Querzoli, P., Negrini, M., and Croce, C M., MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005, 65: 7065-7070.
31. Ishitani, T., Kishida, S., Hyodo-Miura, J., Ueno, N., Yasuda, J., Waterman, M., Shibuya, H., Moon, R. T., Ninomiya-Tsuji, J., and Matsumoto, K., The TAK1-NLK mitogen-activated protein kinase cascade functions in the WNT-5a/Ca2+ pathway to antagonize WNT/ß-catenin signalling. Mol. Cell. Biol. 2003, 23: 131-139.
32. Itoh, T., Kamiya, Y., Okabe, M., Tanaka, M., and Miyajima, A., Inducible expression of Wnt genes during adult hepatic stem/progenitor cell response. FEBS Lett. 2009, 583: 777-781.
33. Jho, E. H., Zhang, T., Domon, C, Joo, C. K., Freund, J.N., and Costantini, F., Wnt/β-Catenin/Tcf Signaling Induces the Transcription of Axin2, a Negative Regulator of the Signaling Pathway. Mol. Cell. Biol. 2002, 22: 1172-1183.
34. Jiang, Y. Zhou, X. D., Liu, Y. K., Wu, X., and Huang, X.W., Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma. World J. Gastroenterol. 2002, 8: 804-807.
35. Jopling, C. L., Yi, M., Lancaster, A. M., Lemon, S. M., and Sarnow, P., Modulation of Hepatitis C virus RNA abundance by a liver-specific microRNA. Science 2005, 309: 1577-1581.
36. Katoh, M., WNT and FGF gene clusters. Int. J. Oncol. 2002, 21: 1269-1273.
37. Katoh, M., and Katoh, M., Identification and characterization of human BCL9L gene and mouse Bcl9l gene in silico. Int. J. Mol. Med. 2003, 12: 643-649.
38. Katoh, M., and Katoh, M., WNT Signaling Pathway and Stem Cell Signaling Network. Clin. Cancer Res. 2007, 13: 4042-4045.
39. Khan, N. I., Bradstock, K. F., and Bendall, L. J., Activation of Wnt/β-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia. Br. J. Haematol. 2007, 138: 338-348.
40. Kirikoshi, H., Sekihara, H., and Katoh, M., Up-regulation of Frizzled-7 FZD7 in human gastric cancer. Int J Oncol. 2001, 19: 111-115.
41. Koch, A., Denkhaus, D., Albrecht, S., Leuschner, I., von Schweinitz, D., and Pietsch, T., Childhood Hepatoblastomas Frequently Carry a Mutated Degradation Targeting Box of the β-Catenin Gene. Cancer Res. 1999, 59: 269-273.
42. Koch, A., Waha, A., Hartmann, W., Hrychyk, A., Schüller, U., Waha, A., Wharton Jr, K. A., Fuchs, S. Y., von Schweinitz, D., and Pietsch, T., Elevated Expression of Wnt Antagonists Is a Common Event in Hepatoblastomas. Clin. Cancer Res. 2005, 11: 4295-4304.
43. Kolligs, F., Nieman, M., Winer, I., Hu, G., Van Mater, D., Feng, Y., Smith, I., Wu, R., Zhai, Y., and Cho, K, ITF- 2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with β-catenin defects and promotes neoplastic transformation. Cancer Cell 2002, 1: 145-155.
44. Kramps, T., Peter, O., Brunner, E., Nellen, D., Froesch, B., Chatterjee, S., Murone, M., Zullig, S., and Basler, K., WNT/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear ß-catenin-TCF complex. Cell 2002, 109: 47-60.
45. Krützfeld, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., and Stoffel, M., Silencing of microRNAs in vivo with'antagomirs'. Nature 2005, 438: 685-689.
46. Kutay, H., Bai, S., Datta, J., Motiwala, T., Pogribny, I., Frankel, W., Jacob, S. T., and Ghoshal, K., Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J. Cell. Biochem. 2006, 99: 671-678.
47. Lagos-Quintana, M., Rauhut, R., Lendeckel, W., and Tuschl, T., Identification of novel genes coding for small expressed RNAs. Science 2001, 294: 853-858.
48. Lee, C. T., Risom, T., and Strauss, W. M., MicroRNAs in mammalian development. Birth Defects Res. Part C: Embryo Today 2006, 78: 129-139.
49. Lee, H. C, Kim, M., and Wands, J. R., WNT/Frizzled signaling in hepatocellular carcinoma. Front. Biosci. 2006, 11: 1901-1915.
50. Lee, R. C, and Ambros, V., An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 249: 862-864.
51. Lee, Y., Kim, M., Han, J., Yeom, K. H, Lee, S., Baek, S. H., and Kim, V.N., MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23: 4051-4060.
52. Levanon, D., Goldstein, R. E., Bernstein, Y., Tang, H., Goldenberg, D., Stifani, S., Paroush, Z., and Groner, Y., Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc. Natl. Acad. Sci. USA 1998, 95: 11590-11595.
53. Liu, C. L., Fan, S. T., Lo, C. M., Ng, I. O. L., Lam, C. M., Poon, R. T. P., and Wang J., Hepatic Resection for Combined Hepatocellular and Cholangiocarcinoma. Arch. Surg. 2003, 138: 86-90.
54. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H, Ferrando, A. A., Downing, J. R., Jacks, T., Horvitz, H. R., and Golub, T. R., MicroRNA expression profiles classify human cancers. Nature 2005, 435: 834-838.
55. Lu, W., Yamamoto, V., Ortega, B., and Baltimore, D., Mammalian Ryk is a WNT coreceptor required for stimulation of neurite outgrowth. Cell 2004, 119: 97-108.
56. Lu, X., Borchers, A. G., Jolicoeur, C, Rayburn, H., Baker, J. C, and Tessier-Lavigne, M., PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates. Nature 2004, 430: 93-98.
57. Lustig, B., and Behrens, J., The Wnt signaling pathway and its role in tumor development. J. Cancer Res. Clin. Oncol. 2003, 129: 199-221.
58. Magrelli, A., Azzalin, G., Salvatore, M., Viganotti, M., Tosto, F., Colombo, T., Devito, R., di Masi, A., Antoccia, A., Lorenzetti, S., Maranghi, F., Mantovani, A., Tanzarella, C, Macino, G., and Taruscio D., Altered microRNA expression patterns in hepatoblastoma patients. Transl Oncol. 2009, 2: 157-163.
59. Mann, D. A., and Smart, D. E., Transcriptional regulation of hepatic stellate cell activation. Gut. 2002, 50: 891-896.
60. Merle, P., de la Monte, S., Kim, M., Herrmann, M., Tanaka, S., Von Dem Bussche, A., Kew, M.C., Trepo, C, Wands, J.R., Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma.Gastroenterology. 2004, 127:1110-1122.
61. Miller, J. R, Hocking, A. M., Brown J. D., and Moon, R.T., Mechanism and function of signal transduction by the Wnt/β-catenin and Wnt/Ca2+ pathways. Oncogene 1999, 18: 7860-7872.
62. Miller, J. R., The Wnts. Genome Biol. 2002, 3: 1-15.
63. Moon, R. T., Kohn, A. D., De Ferrari, G. V., and Kaykas, A., WNT and β-catenin signalling: diseases and therapies. Nat. Rev. Genet. 2004, 5: 691-701.
64. Murray, C, and Lopez, A., Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. The Lancet 1997, 349: 1436-1442.
65. Nhieu, J. T. V., Renard, C. A., Wei, Y., Cherqui, D., Zafrani, E. S., and Buendia, M. A., Nuclear Accumulation of Mutated ß-Catenin in Hepatocellular Carcinoma Is Associated with Increased Cell Proliferation. Am. J. Pathol. 1999, 155: 703-710.
66. O'Donnell, K A., Wentzel, E. A., Zeller, K. I., Dang, C. V., and Mendell, J. T., c-Myc-regulated microRNAs modulate E2F1expression. Nature 2005, 435: 839-843.
67. Oishi, I., Suzuki, H, Onishi, N., Takada, R., Kani, S., Ohkawara, B., Koshida, I., Suzuki, K, Yamada, G., Schwabe, G. C, Mundlos, S., Shibuya, H., Takada, S., and Minami, Y., The receptor tyrosine kinase Ror2 is involved in non-canonical WNT5a/JNK signaling pathway. Genes Cells 2003, 8: 645-654.
68. Paoni, N. F., Feldman, M. W., Gutierrez, L. S., Ploplis, V.A., and Castellino F.J., Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/mouse. Physiol. Genomics 2003, 15: 228-235.
69. Peifer, M., and Polakis, P., Wnt Signaling in Oncogenesis and Embryogenesis-a Look Outside the Nucleus. Science 2000, 287: 1606-1609.
70. Pennica, D., Swanson, T. A., Welsh, J. W., Roy, M. A., Lawrence, D. A., Lee, J., Brush, L. A., Taneyhill, L. A., Deuel, B., Lew, M., Watanabe, C, Cohen, R. L., Melhem, M.F., Finley, G. G., Quirke, P., Goddard, A. D., Hillan, K. J., Gurney, A. L., Botstein, D., and Levine, A. J., WISP genes are members of the connective tissue growth factor family that are up-regulated in WNT1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. USA 1998, 95: 14717-14722.
71. Perilongo, G., Plaschkes, J., and Zimmermann, A., In: Hepatic tumours, Souhami, R. L., Tannock, I., Hohenberger, P., Horiot J. C, Oxford Textbook of Oncology 2nd Ed., Oxford 2002, pp. 2657-2668.
72. Reichling, T., Goss, K. H., Carson, D. J., Holdcraft, R. W., Ley-Ebert, C, Witte, D., Aronow, B. J., and Groden, J., Transcriptional profiles of intestinal tumors in ApcMin mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors. Cancer Res. 2005, 65: 166-176.
73. Roebuck, D. J., and Perilongo, G., Hepatoblastoma: an oncological review. Pediatr. Radiol. 2006, 36: 183-186.
74. Roose, J., Molenaar, M., Peterson, J., Hurenkamp, J., Brantjes, H, Moerer, P., van de Wetering, M., Destree, O., and Clevers, H., The Xenopus WNT effector XTcf-3 interacts with Groucho-related transcriptional repressors. Nature 1998, 395: 608-612.
75. Sagara, N, Toda, G., Hirai, M., Terada, M., and Katoh, M., Molecular Cloning, Differential Expression, and Chromosomal Localization of HumanFrizzled-1, Frizzled-2, and Frizzled-7. Biochem. Biophys. Res. Comm. 1998, 252: 117-122.
76. Sareddy, G. R., Panigrahi, M., Challa, S., Mahadevan, A., and Babu, P. P., Activation of Wnt/β-catenin/Tcf signaling pathway in human astrocytomas. Neurochem. Int. 2009, 55: 307-317.
77. Schafer, D. F., and Sorrell M. F., Hepatocellular carcinoma. The Lancet 1999, 353: 1253-1257.
78. Schepers, G. E., Teasdale, R. D., and Koopman, P., Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev. Cell 2002, 3: 167-170.
79. Schnater, J. M., Köhler, S. E., Lamers, W. H., von Schweinitz, D., Aronson, D. C, Where do we stand with hepatoblastoma? A review. Cancer 2003, 98: 668-678.
80. Scott, G. K., Goga, A., Bhaumik, D., Berger, C. E., Sullivan, C. S., and Benz, C. C, Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J. Biol. Chem. 2007, 282: 1479-1486.
81. Shibata, T., Chuma, M., Kokubu, A., Sakamoto, M., and Hirohashi, S., EBP50, a β-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology 2003, 38: 178-186.
82. Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C, D'Amico, M., Pestell, R., and Ben-Ze'ev, A. The cyclin D1 gene is a target of the b-cateninyLEF-1 pathway. Proc. Natl. Acad. Sci. USA 1999, 96: 5522-5527.
83. Sinner, D., Kordich, J. J., Spence, J. R., Opoka, R., Rankin, S., Lin, S. C, Jonatan, D., Zorn, A. M., and Wells J. M., Sox17 and Sox4 differentially regulate β-catenin/T-cell factor activity and proliferation of colon carcinoma cells. Mol. Cell. Biol. 2007, 27: 7802-7815.
84. Takigawa, Y., and Brown, A. M., Wnt signaling in liver cancer. Curr. Drug Targets 2008, 9: 1013-1024.
85. Tanaka, S., Akiyoshi, T., Mori, M., Wands, J.R., Sugimachi, K. A novel frizzled gene identified in human esophageal carcinoma mediates APC/β-catenin signals. Proc Natl Acad Sci U S A 1998, 95: 10164-10169.
86. Taniguchi, K., Roberts, L. R., Aderca, I. N., Dong, X., Qian, C, Murphy, L. M., Nagorney, D. M., Burgart, L. J., Roche, P. C, Smith, D. I., Ross, J. A., and Liu, W., Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 2002, 21: 4863-4871.
87. Tao, W., Pennica, D., Xu, L., Kalejta, R. F., and Levine, A. J., Wrch-1, a novel member of the Rho gene family that is regulated by WNT-1. Genes Dev. 2001, 15: 1796-1807.
88. Tetsu, O., and McCormick, F., β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398: 422-426.
89. Varnholt, H., The role of microRNAs in primary liver cancer. Annals of Hepatology 2008, 7: 104-113.
90. Vincan, E., Darcy, P. K., Smyth, M. J. Thompson, E. W., Thomas, R. J. S., Phillips, W. A., and Ramsay, R.G., Frizzled-7 receptor ectodomain expression in a colon cancer cell line induces morphological change and attenuates tumor growth. Differentiation 2005, 73: 142-153.
91. Vincan, E., Swain, R. K., Brabletz, T., and Steinbeisser, H., Frizzled7 dictates embryonic morphogenesis: implications for colorectal cancer progression. Front. Biosci. 2007, 12: 4558-4567.
92. Volinia, S., Calin, G. A., Liu, C. G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C, Ferracin, M., Prueitt, R. L., Yanaihara, N., Lanza, G., Scarpa, A., Vecchione, A., Negrini, M., Harris, C. C, and Croce, C. M., A microRNA expression signature of Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J. Biol. Chem. 2006, 282: 1479-1486.
93. Wang, L., Li, H, Zhang, Y., Santella, R. M., and Weinstein, I. B., HINT1 inhibits β-catenin/TCF4, USF2 and NFkappaB activity in human hepatoma cells. Int. J. Cancer 2009, 124: 1526-1534.
94. Wei, Y., Fabre, M., Branchereau, S., Gauthie, F., Perilongo, G., Buendia, M. A., Activation of β-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 2000, 19: 498-504.
95. Yamamoto, Y., Sakamoto, M., Fujii, G., Tsuiji, H, Kenetaka, K., Asaka, M., and Hirohashi, S., Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with β-catenin mutations. Hepatology 2003, 37: 528-533.
96. Yanaihara, N, Caplen, N, Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., Calin, G. A., Liu, C. G., Croce, C. M., and Harris, C. C, Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9: 189-198.
97. Yoon, S. Y., Jeong, M. J., Yoo, J., Lee, K. I., Kwon, B. M., Lim, D. S., Lee, C. E., Park, Y. M., and Han, M. Y., Grb2 dominantly associates with dynamin II in human hepatocellular carcinoma HepG2 cells. J. Cell Biochem. 2001, 84: 150-155.
98. Zeng, G., Apte, U., Cieply, B., Singh, S., and Monga, S. P. S., siRNA-Mediated β-Catenin Knockdown in Human Hepatoma Cells Results in Decreased Growth and Survival Neoplasia. Oncogene 2007, 9: 951-959.
99. Zhou, B., Wang, S., Mayr, C, Bartel, D. P., and Lodish, H. F., miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc. Natl. Acad. Sci. USA 2007, 104: 7080-7085
100. Zorn, A. M., Barish, G. D., Williams, B. O., Lavender, P., Klymkowsky, M. W., and Varmus, H. E., Regulation of WNT signaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with β-catenin. Mol. Cell 1999, 4: 487-498.